Major crippling diseases worldwide may be amenable to treatment with inhibitors of a system that controls bone loss, according to a review of the molecular events in bone metabolism and arthritis.

The balance between bone loss by osteoclasts and bone formation by osteoblasts in normal bone metabolism is controlled …